3 min readNew era in nasopharyngeal cancer: Toripalimab opens doors for immunotherapy.For decades, nasopharyngeal cancer patients facing recurrent or metastatic disease had limited treatment options.
4 min readCould anti-BNLF2b antibody change nasopharyngeal cancer screening?Nasopharyngeal cancer is a challenging adversary in the field of oncology. It is often diagnosed at advanced stages.
